Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase II Trial of Alemtuzumab and Rituximab in Patients With Previously Untreated CLL
This study is ongoing, but not recruiting participants.
Study NCT00858117   Information provided by Northwestern University

First Received on March 6, 2009.   Last Updated on March 19, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leukemia
More general conditions related to this trial
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
Alemtuzumab
Rituximab
Additional drug interventions recognized in this trial
Antibodies, Neoplasm
Campath 1G
More general drug interventions related to this trial
Antineoplastic Agents
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Northwestern University
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services